Review
Immunology
Shiyu Huang, Tomoharu Yasuda
Summary: The Epstein-Barr virus is common in humans and can lead to lymphoproliferative diseases which may develop into lymphoma. The immune system plays a role in monitoring EBV+ B cells to prevent tumor formation.
FRONTIERS IN IMMUNOLOGY
(2021)
Article
Biology
Shuming Yin, Lie Ma, Tingting Shao, Mei Zhang, Yuting Guan, Liren Wang, Yaqiang Hu, Xi Chen, Honghui Han, Nan Shen, Wenjuan Qiu, Hongquan Geng, Yongguo Yu, Shichang Li, Weishi Yu, Mingyao Liu, Dali Li
Summary: This study demonstrates a novel strategy to significantly increase AAV transduction efficiency through co-delivery of AAVR and AAV vectors, thus greatly enhancing in vivo genome editing efficiency and therapeutic effects, showing clinical potential for gene therapy.
SCIENCE CHINA-LIFE SCIENCES
(2022)
Review
Urology & Nephrology
Rei Bufi, Ron Korstanje
Summary: The mouse is commonly used to study kidney disease, but genetic background differences and effects need to be considered. Choosing the right mouse strain can improve translational research and make the results more applicable to humans. Using genetically diverse mice can provide results that better reflect the variation in human disease outcomes. Therefore, embracing the genetic diversity in mice is important for better translational research methods.
KIDNEY INTERNATIONAL
(2022)
Review
Neurosciences
Jing Wang, Mengna Zhu, Jingyi Sun, Lina Feng, Mingfeng Yang, Baoliang Sun, Leilei Mao
Summary: Stroke is associated with devastating clinical outcomes, and current treatment strategies are largely ineffective. Gene therapy using adeno-associated viruses (AAVs) as gene vectors has emerged as a promising approach for treating central nervous system diseases. This review provides an overview of the biological characteristics of AAV vectors and therapeutic advancements in preclinical models of ischemic stroke. It further investigates the potential of manipulating AAV vectors in preclinical applications, emphasizing the challenges and prospects in viral vector selection, drug delivery strategies, immune reactions, and clinical translation.
CNS NEUROSCIENCE & THERAPEUTICS
(2023)
Article
Multidisciplinary Sciences
Yuqing Wang, Ayrea Hurley, Marco De Giorgi, Mark R. Tanner, Rong-Chi Hu, Michael W. Pennington, William R. Lagor, Christine Beeton
Summary: Targeting the Kv1.3 potassium channel has shown effectiveness in reducing obesity and severity of autoimmune disease in animal models. However, the delivery of Kv1.3 blockers like Stichodactyla toxin (ShK) requires injections, which affects patient compliance. A study using Adeno-Associated Virus (AAV)8 vectors to induce hepatocytes to express the Kv1.3 blocker showed promising results in mice but was ineffective in reducing obesity in mice fed a high-fat diet.
Article
Biochemistry & Molecular Biology
Amira D. Rghei, Laura P. van Lieshout, Benjamin M. McLeod, Yanlong Pei, Jordyn A. Lopes, Nicole Zielinska, Enzo M. Baracuhy, Brenna A. Y. Stevens, Sylvia P. Thomas, Jacob G. E. Yates, Bryce M. Warner, Darwyn Kobasa, Hugues Fausther-Bovendo, Gary P. Kobinger, Khalil Karimi, Brad Thompson, Byram W. Bridle, Leonardo Susta, Sarah K. Wootton
Summary: The study demonstrated the safety and scalability of AAV vector mediated expression of human antibodies in a large animal model, sheep, with steady increase in antibody expression and no signs of toxicity observed.
Review
Endocrinology & Metabolism
Marcel A. Chuecos, William R. Lagor
Summary: The liver is an ideal target for gene therapy of inherited metabolic disorders (IMDs), and adeno-associated viral (AAV) vectors have shown high efficiency and safety in delivering transgenes to the liver. Ongoing research has provided important insights into AAV capsid serotypes with liver tropism, and successful clinical trials have been conducted for hemophilia. Overcoming neutralizing antibodies and minimizing immune responses are crucial for achieving therapeutic benefits. Combining AAV delivery with genome editing holds promise for precise gene expression control. However, the risk of tumorigenesis and hepatotoxicity remains concerns for AAV liver gene therapy.
JOURNAL OF INHERITED METABOLIC DISEASE
(2023)
Article
Cell Biology
Wen Y. Ding, Valeryia Kuzmuk, Sarah Hunter, Abigail Lay, Bryony Hayes, Matthew Beesley, Ruth Rollason, Jennifer A. Hurcombe, Fern Barrington, Catrin Masson, William Cathery, Carl May, Jack Tuffin, Timothy Roberts, Geraldine Mollet, Colin J. Chu, Jenny McIntosh, Richard J. Coward, Corinne Antignac, Amit Nathwani, Gavin I. Welsh, Moin A. Saleem
Summary: Gene therapy using AAV vector has successfully addressed the challenges of kidney diseases, showing particular success in targeting monogenic diseases in other organs. By utilizing AAV-LK03 and AAV 2/9, gene therapy has been able to rescue genetic defects and improve kidney disease in human and mouse models, establishing the podocyte as a viable target for gene therapy.
SCIENCE TRANSLATIONAL MEDICINE
(2023)
Article
Clinical Neurology
Amanda L. Gross, Heather L. Gray-Edwards, Cassie N. Bebout, Nathan L. Ta, Kayly Nielsen, Brandon L. Brunson, Kalajan R. Lopez Mercado, Devin E. Osterhoudt, Ana Rita Batista, Stacy Maitland, Thomas N. Seyfried, Miguel Sena-Esteves, Douglas R. Martin
Summary: Researchers have found that intravenous administration of AAV9 vector can effectively treat GM1 gangliosidosis, increasing the lifespan of animals and improving their quality of life and neurological function. After treatment, neurological abnormalities were mild, CSF biomarkers were normalized, and urinary glycosaminoglycans decreased to normal levels.
Article
Multidisciplinary Sciences
Tobias P. Woerner, Antonette Bennett, Sana Habka, Joost Snijder, Olga Friese, Thomas Powers, Mavis Agbandje-McKenna, Albert J. R. Heck
Summary: Recent research on Adeno-associated viruses (AAVs) using high-resolution native mass spectrometry has revealed that the capsids of different AAV serotypes assemble stochastically, leading to a highly heterogeneous population of capsids with varying compositions. Even the most abundant VP stoichiometry represents only a small percentage of the total AAV population. The systematic scoring of simulations against experimental native MS data offers a sensitive new method to characterize these therapeutically important heterogeneous capsids.
NATURE COMMUNICATIONS
(2021)
Article
Microbiology
Edward E. Large, Michael S. Chapman
Summary: Adeno-associated viruses (AAV) are widely used for gene therapy, and monoclonal antibodies against various AAV serotypes have been developed. Previous studies suggested that neutralizing antibodies inhibit binding to glycan receptors or interfere with post-entry steps. However, recent research has identified a protein receptor and revealed that antibody interference with protein receptor binding may be the predominant mechanism of neutralization.
FRONTIERS IN MICROBIOLOGY
(2023)
Article
Microbiology
Fei Huang, Meishen Ren, Jie Pei, Hong Mei, Baokun Sui, Qiong Wu, Benjie Chai, Ruicheng Yang, Ming Zhou, Zhen F. Fu, Huiping Zhou, Ling Zhao
Summary: The study showed that AAV-encoding RVNA can be used as a potential postexposure prophylaxis for human rabies.
FRONTIERS IN MICROBIOLOGY
(2021)
Article
Pathology
Laura Mairinoja, Hanna Heikela, Sami Blom, Darshan Kumar, Anna Knuuttila, Sonja Boyd, Nelli Sjoblom, Eva-Maria Birkman, Petteri Rinne, Pekka Ruusuvuori, Leena Strauss, Matti Poutanen
Summary: The incidence of nonalcoholic fatty liver disease is increasing worldwide, and there is a need for new methods to study its manifestation and analyze drug efficacy in preclinical models. This study developed a deep neural network-based model to quantify different types of steatosis in the liver on stained whole slide images. The algorithm accurately detected liver parenchyma, excluded blood vessels and artifacts, differentiated microvesicular and macrovesicular steatosis, and quantified the recognized tissue area. The results correlated well with expert pathologists' evaluation and liver fat content measurements, demonstrating the reliability of the model.
AMERICAN JOURNAL OF PATHOLOGY
(2023)
Article
Multidisciplinary Sciences
Justin L. Tosh, Elena R. Rhymes, Paige Mumford, Heather T. Whittaker, Laura J. Pulford, Sue J. Noy, Karen Cleverley, Matthew C. Walker, Victor L. J. Tybulewicz, Rob C. Wykes, Elizabeth M. C. Fisher, Frances K. Wiseman
Summary: Individuals with Down syndrome have a higher risk of early-onset Alzheimer's disease due to the accumulation of amyloid-beta in the brain, which is caused by an extra copy of the chromosome 21 gene APP. Other chromosome 21 genes are also likely to influence Alzheimer's disease in people with Down syndrome.
SCIENTIFIC REPORTS
(2021)
Article
Biochemistry & Molecular Biology
Kaja Blagotinsek Cokan, Ziga Urlep, Miha Moskon, Miha Mraz, Xiang Yi Kong, Winnie Eskild, Damjana Rozman, Peter Juvan, Tadeja Rezen
Summary: Through mouse models, it was found that various genetic models of liver fibrosis exhibit a common transcriptional program and downregulated lipid pathways, while different metabolic subtypes of liver fibrosis were proposed, aiding in improved stratification of other fibrosis-related pathologies.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2021)
Article
Biochemistry & Molecular Biology
Timothy J. Humpton, Holly Hall, Christos Kiourtis, Colin Nixon, William Clark, Ann Hedley, Robin Shaw, Thomas G. Bird, Karen Blyth, Karen H. Vousden
Summary: p53 is a crucial transcription factor that plays a role as a tumor suppressor and regulates cell elimination, survival, and repair in response to stress. Studies have shown that p53 is involved in liver repair from CCl4-induced damage and limits the development of HCC, partly through the activation of detoxification cytochrome P450 CYP2A5/CYP2A6.
CELL DEATH AND DIFFERENTIATION
(2022)
Review
Gastroenterology & Hepatology
Daniel Geh, Jack Leslie, Rob Rumney, Helen L. Reeves, Thomas G. Birds, Derek A. Mann
Summary: The success of atezolizumab plus bevacizumab treatment has led to a shift towards combination therapies in the treatment of hepatocellular carcinoma (HCC) that include cancer immunotherapies. The focus of cancer immunotherapy has primarily been on immune checkpoints, but emerging evidence supports the role of neutrophils as important contributors to the development and progression of HCC. Neutrophil-targeted therapies are now being explored in clinical trials and may have therapeutic benefits, including enhancing the effectiveness of conventional immunotherapy.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY
(2022)
Article
Biochemistry & Molecular Biology
Timothy J. Humpton, Andreas K. Hock, Christos Kiourtis, Marco De Donatis, Frederic Fercoq, Colin Nixon, Sheila Bryson, Douglas Strathdee, Leo M. Carlin, Thomas G. Bird, Karen Blyth, Karen H. Vousden
Summary: Genetically encoded probes are commonly used to visualize cellular processes, but traditional fluorescent protein tags are suboptimal for in vivo studies due to poor tissue penetration and high background signal. A new knock-in reporter mouse model linking near-infrared fluorescent protein expression to a synthetic p53-responsive promoter enables noninvasive, longitudinal analysis of p53 activity in vivo. This model has provided insights into the timing and localization of p53 activation in response to various stimuli, potentially advancing our understanding of physiological and pathophysiological p53 responses.
Article
Pathology
Lucy M. V. Gee, Ben Barron-Millar, Jack Leslie, Claire Richardson, Marco Y. W. Zaki, Saimir Luli, Rachel A. Burgoyne, Rainie I. T. Cameron, Graham R. Smith, John G. Brain, Barbara Innes, Laura Jopson, Jessica K. Dyson, Katherine R. C. McKay, Alexandros Pechlivanis, Elaine Holmes, Rolando Berlinguer-Palmini, Stella Victorelli, George F. Mells, Richard N. Sandford, Jeremy Palmer, John A. Kirby, Christos Kiourtis, Joao Mokochinski, Zoe Hall, Thomas G. Bird, Lee A. Borthwick, Christopher M. Morris, Peter S. Hanson, Diana Jurk, Elizabeth A. Stoll, Fiona E. N. LeBeau, David E. J. Jones, Fiona Oakley
Summary: Patients with cholestatic liver disease can experience cognitive impairments, but the underlying cellular mechanisms are poorly understood. This study used a rodent model and human neuronal cell cultures to explore the neurocognitive symptoms and potential therapies. The results showed that obeticholic acid, a second-line anti-cholestatic agent, could normalize memory function and reverse neuronal senescence.
AMERICAN JOURNAL OF PATHOLOGY
(2023)
Article
Food Science & Technology
Stephanie May, Kirsty R. Greenow, Adam T. Higgins, Anna Derrick, Elaine Taylor, Pan Pan, Maria Konstantinou, Colin Nixon, Thomas E. Wooley, Owen J. Sansom, Li-Shu Wang, Lee Parry
Summary: Black raspberries have a protective effect on normal and mutant intestinal stem cells, and can prevent the occurrence of colorectal cancer.
MOLECULAR NUTRITION & FOOD RESEARCH
(2022)
Article
Biochemistry & Molecular Biology
Victor H. Villar, Maria Francesca Allega, Ruhi Deshmukh, Tobias Ackermann, Mark A. Nakasone, Johan Vande Voorde, Thomas M. Drake, Janina Oetjen, Algernon Bloom, Colin Nixon, Miryam Muller, Stephanie May, Ee Hong Tan, Lars Vereecke, Maude Jans, Gillian Blancke, Daniel J. Murphy, Danny T. Huang, David Y. Lewis, Thomas G. Bird, Owen J. Sansom, Karen Blyth, David Sumpton, Saverio Tardito
Summary: This study reveals that glutamine synthetase (GS) can produce a methylated glutamine analog, N-5-methylglutamine, during the synthesis of glutamine. GS inhibition leads to decreased levels of N-5-methylglutamine in the liver and circulation in mice. The levels of N-5-methylglutamine in urine correlate with tumor burden and GS expression in a liver cancer model.
NATURE CHEMICAL BIOLOGY
(2023)
Article
Gastroenterology & Hepatology
Stephanie May, Miryam Mueller, Callum R. Livingstone, George L. Skalka, Peter J. Walsh, Colin Nixon, Ann Hedley, Robin Shaw, William Clark, Johan Vande Voorde, Leah Officer-Jones, Fiona Ballantyne, Ian R. Powley, Thomas M. Drake, Christos Kiourtis, Andrew Keith, Ana Sofia Rocha, Saverio Tardito, David Sumpton, John Le Quesne, Martin Bushell, Owen J. Sansom, Thomas G. Bird
Summary: By characterizing and comparing the Axin2CreERT2 model, conflicting results regarding the crucial subpopulations of hepatocytes involved in liver regeneration were reconciled. This study highlights the importance of detailed preclinical model characterization and the pitfalls that may arise from comparing across sexes and backgrounds of mice and the effects of genetic insertion into native loci.
JOURNAL OF HEPATOLOGY
(2023)
Editorial Material
Biology
Stephanie May, Thomas G. Bird
Summary: After fasting, hepatocytes undergo proliferation to facilitate the regeneration of the liver to its original size.